After the Special Meeting upon approval of the Reverse Stock Split, the remaining F-22 On February 14, 2023, the Company completed a The Company has authorized On May 31, 2023, the Company entered into the Open Market Sale Agreement with Jefferies pursuant to which Jefferies is serving as the Companys sales agent to sell shares of the Companys common stock through an at-the-market offering. As of June 13, 2023, the Company was authorized to offer and sell up to $ During the years ended December 31, 2023 and 2022, the Company issued During the years ended December 31, 2023 and 2022, the Company issued During the years ended December 31, 2023 and 2022, the Company issued 14
But with with its amazing benefits come some potential concerns around its safety and potential side effects
In the context of MIC injections, methionine is included for its potential to help the liver process fats more efficiently and prevent excess fat accumulation in liver tissue
About Setria Glutathione Setria Glutathione, developed by Kyowa Hakko Bio Co., Ltd., is a clinically researched, patented antioxidant that supports cellular and mitochondrial health
.png)
